Close

Ascendis Pharma (ASND) Initiates Phase 3 Trial for TransCon Growth Hormone in Children with GHD

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/25/2024

1. TSLA
2. META
3. ENPH
4. TXN
5. BA
6. SPOT
7. IBM
8. V
9. HCP
10. CMG


Go back to Ascendis Pharma (ASND) Initiates Phase 3 Trial for TransCon Growth Hormone in Children with GHD
Asianada, Inc. (NASDAQ: ASND) Delayed: 143.18 --0 (-0%)
Previous Close $143.18    52 Week High $21.79 
Open $143.18    52 Week Low $11.92 
Day High $143.18    P/E N/A 
Day Low $143.18    EPS $-0.07 
Volume 101